Company intelligence / Profile preview

Chorus Life Sciences

Ownership: Public · CNU
Development stage: Commercial

Overview

Chorus Life Sciences Ltd. is a Canada-based pharmaceutical and nutraceutical company with over two decades of experience supplying high-quality medications worldwide. The company focuses on cost-effective solutions without compromising quality, offering a comprehensive portfolio across oral, topical, and parenteral dosage forms for global markets including regulated regions such as the Americas, MENA, and CIS. Their facilities are certified by regulatory authorities internationally.

Therapeutic areas: Infectious Diseases
Modalities: Small moleculeNutraceuticals
Industry: Biotech

Drug pipeline

4 assets

LY2189102

Phase 2

Indications: Type 2 diabetes

3 more assets in the full pipeline.

Request access →

Financials

Market cap: $76.2M
Total revenue: $0
Enterprise value: $-32.9M

Beyond the preview

Go deeper on Chorus Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chorus Life Sciences.

Explore the full profile